Iranian Scientists Unveil Homegrown Medicine for ALS Patients

Iranian researchers have unveiled a domestically-produced medicine for ALS patients or those suffering from amyotrophic lateral sclerosis.

The medication was recently unveiled in the presence of the country’s Vice President for Science and Technology Sorena Sattari.

The drug, produced by a knowledge-based company at the University of Medical Sciences, has been on the market for two months and been used by about 50 patients.

Alsava is a thick product that is prescribed for patients with ALS.

ALS causes damage to motor cells in the spinal cord and brain and is a type of degenerative disease.

There are no known causes for this disease in most cases. People over the age of 50 may develop ALS, but it’s been seen at younger ages as well. According to neurologists, the disease is not treatable.

Acclaimed physicist Stephen Hawking was suffering from this disease and lost his life in 2018.

Iran Becomes Region’s Top Country in Biotechnology: VP

Iran’s Knowledge-Based Companies Withstanding US Sanctions: VP

Iran Says Focused on Producing Goods Sanctioned by US

IFP Editorial Staff

The IFP Editorial Staff is composed of dozens of skilled journalists, news-writers, and analysts whose works are edited and published by experienced editors specialized in Iran News. The editor of each IFP Service is responsible for the report published by the Iran Front Page (IFP) news website, and can be contacted through the ways mentioned in the "IFP Editorial Staff" section.